Munafa Stock Market Course + Intraday & FNO calls 
MANKIND NEWS why is Mankind Pharma Limited price falling or rising
MANKIND NEWS reasons for why stock price of Mankind Pharma Limited is falling or rising
MANKIND Mankind Pharma is falling or rising technical reasons
Technical analysis forecast for Mankind Pharma Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Mankind Pharma MANKIND at this time. Stock is falling and might fall more.
It appears as if Mankind Pharma MANKIND gave a large move recently.
Stock of Mankind Pharma (MANKIND) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
Although my analysis for Mankind Pharma is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 2352.3, for a target of 2384.6 or 2411.43
MANKIND Mankind Pharma is falling or rising NEWS fundamental reasons
Company Announcement Mankind Pharma Limited has informed the Exchange about General Updates - NEWS as on 2026-09-01
Company Announcement Mankind Pharma Limited has informed the Exchange regarding Cessation of Mr Bharat Anand as Non- Executive Independent Director of the company w.e.f. August 30, 2026. - NEWS as on 2026-08-31
Company Announcement - NEWS as on 2026-08-27
Mankind Pharma signs in-licensing deal for Insulin Aspart and Insulin Degludec Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with Chongqing Chenan Biopharmaceutical Co., China, for the commercialisation of two insulin analogues, Insulin Degludec and Insulin Degludec + Aspart Combination, in India. - NEWS as on 2026-08-21 business-standard.com
Company Announcement Mankind Pharma Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India". - NEWS as on 2026-08-20
Company Announcement Mankind Pharma Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-08-19
Company Announcement Mankind Pharma Limited has informed the Exchange regarding Notice of Postal Ballot - NEWS as on 2026-08-18
More announcements and NEWS
MANKIND Mankind Pharma Limited current price & indicator signals
Recent prices of MANKIND Mankind Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 01 Tue Sep 2026 | 2356.50 | 2350.00 to 2381.40 | -2.59% | 0.84 times |
| 31 Mon Aug 2026 | 2419.20 | 2343.60 to 2419.20 | 1.52% | 1.17 times |
| 28 Fri Aug 2026 | 2382.90 | 2370.00 to 2422.10 | -1.43% | 0.57 times |
| 27 Thu Aug 2026 | 2417.50 | 2377.60 to 2417.50 | 0.99% | 0.96 times |
| 26 Wed Aug 2026 | 2393.70 | 2358.00 to 2423.90 | 1.21% | 1.53 times |
| 25 Tue Aug 2026 | 2365.00 | 2337.60 to 2374.40 | -0.4% | 1.24 times |
| 24 Mon Aug 2026 | 2374.50 | 2367.10 to 2385.10 | -0.4% | 0.39 times |
| 21 Fri Aug 2026 | 2384.00 | 2365.60 to 2407.20 | -0.04% | 1.02 times |
| 20 Thu Aug 2026 | 2385.00 | 2373.40 to 2413.00 | -0.38% | 0.92 times |
| 19 Wed Aug 2026 | 2394.00 | 2380.00 to 2423.00 | 0.59% | 1.1 times |
| 18 Tue Aug 2026 | 2380.00 | 2363.30 to 2395.00 | -0.04% | 1.09 times |
| 17 Mon Aug 2026 | 2380.90 | 2369.50 to 2423.00 | -1.83% | 2.42 times |
Videos related to: MANKIND NEWS why is Mankind Pharma Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
